Astera Labs: Sell-Off Already Priced In 2027 Stall (NASDAQ:ALAB)
· seekingalpha.com
Astera Labs remains a buy, as the market has already priced in a 2027 customer plateau, underestimating new 2H27 ramp-ups. Learn more about ALAB stock here.
I am rating Astera Labs, Inc. ( ALAB ) with a Buy, alongside a 12-month target price of $265.52, which is 18.9% above the November 4 close of $223.27, the first...